Gary Ostroff

Gary Ostroff, PhD, is a Professor at UMass Chan Medical School with cross-disciplinary appointments in the RNA Therapeutics Institute and Pediatrics Department. His research focuses on glucan particle-based vaccine platforms, nanoparticle drug delivery, and host-pathogen interactions.

• Program in Molecular Medicine
• NeuroNexus Institute
• RNA Therapeutics Institute
• Interdisciplinary Graduate Program

Education

• BS in Biology, Delaware Valley College
• PhD in Molecular Medicine, University of Delaware

His work spans immunology, microbiology, and parasitology, with recent publications on targeted antifungal delivery, anthelmintic Cry proteins, and terpene encapsulation. Articles show increasing focus on translational science and cross-protective vaccines.

Key collaborations include Stuart Levitz, Raffi Aroian, and Charles Specht. Notable translation applications include human macrophage targeting, large animal parasitic treatments, and oral vaccine delivery.